What is an example of a hepatotoxic drug?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hepatotoxic Drug Examples

Acetaminophen is the most common and clinically significant hepatotoxic drug, serving as the leading cause of drug-induced liver failure in the United States. 1

Primary Hepatotoxic Medications

Acetaminophen (Paracetamol)

  • Acetaminophen can cause fulminant hepatic failure, particularly at doses exceeding 4 grams per day, making it the most frequently encountered hepatotoxic agent in clinical practice. 2
  • Even at therapeutic doses (≤4g daily), acetaminophen can cause hepatotoxicity in chronic alcohol users, though this remains controversial with mixed evidence. 2, 1
  • The hepatotoxicity results from the toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI), which depletes hepatic glutathione stores and causes hepatic necrosis. 3, 4

Antituberculosis Medications

  • Among first-line antituberculosis agents, pyrazinamide is considered the most hepatotoxic drug. 2, 1
  • Isoniazid, rifampin, and pyrazinamide all cause drug-induced liver injury, with the rifampin-pyrazinamide combination being particularly dangerous and now generally not recommended for latent TB treatment. 2, 1
  • The rifampin-pyrazinamide regimen has caused severe liver injury requiring transplantation and should never be offered to patients with underlying liver disease, concurrent hepatotoxic medications, or excessive alcohol use. 2

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

  • NSAIDs are responsible for approximately 10% of all drug-induced hepatitis cases and cause increased toxicity in patients with existing liver disease due to higher free drug concentrations. 2, 1
  • NSAIDs cause multiple complications beyond hepatotoxicity, including nephrotoxicity, gastric ulcers, and hepatic decompensation in cirrhotic patients, warranting avoidance whenever possible. 2

High-Risk Populations

Patients with Increased Susceptibility

  • Chronic alcohol users demonstrate increased susceptibility to acetaminophen hepatotoxicity, even at doses below 4 grams daily. 2, 1
  • Patients with underlying liver disease, previous drug-induced liver injury, or those taking concurrent hepatotoxic medications face substantially elevated risk. 2, 1
  • Fasting or malnourished states may increase susceptibility through glutathione depletion and cytochrome P-450 2E1 induction. 3

Clinical Recognition and Monitoring

Diagnostic Thresholds

  • Drug-induced hepatitis is suspected when ALT levels reach ≥5 times the upper limit of normal in asymptomatic patients, or ≥3 times the upper limit with hepatitis symptoms. 1
  • Acetaminophen overdose characteristically produces extremely high transaminase levels (AST and ALT >1000 IU/L), distinguishing it from most other causes of liver injury. 3

Management Principles

  • When hepatotoxicity is suspected, immediately discontinue all potentially offending drugs and perform comprehensive causality assessment. 2, 1
  • For acetaminophen overdose, N-acetylcysteine is highly effective when administered within 15 hours of ingestion and remains the standard antidote. 3, 5

Special Dosing Considerations

Patients with Liver Disease

  • In cirrhotic patients, limit acetaminophen to 2-3 grams daily rather than the standard 4-gram maximum, as the half-life increases several-fold and bioavailability quadruples in hepatocellular carcinoma patients. 2
  • Avoid NSAIDs entirely in patients with liver cirrhosis due to compounded risks of hepatotoxicity, nephrotoxicity, and decompensation. 2, 1

References

Guideline

Hepatotoxicity of Common Medications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acetaminophen hepatotoxicity: An update.

Current gastroenterology reports, 1999

Research

Acetaminophen hepatotoxicity.

Clinics in liver disease, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.